ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 40 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $70,000 | +84.2% | 198,480 | 0.0% | 0.00% | – |
| Q1 2020 | $38,000 | -83.1% | 198,480 | -80.8% | 0.00% | – |
| Q4 2019 | $225,000 | -5.1% | 1,031,210 | 0.0% | 0.00% | – |
| Q3 2019 | $237,000 | -6.7% | 1,031,210 | 0.0% | 0.00% | – |
| Q2 2019 | $254,000 | -48.6% | 1,031,210 | 0.0% | 0.00% | – |
| Q1 2019 | $494,000 | +23.8% | 1,031,210 | 0.0% | 0.00% | – |
| Q4 2018 | $399,000 | -35.3% | 1,031,210 | +23.8% | 0.00% | -100.0% |
| Q3 2018 | $617,000 | – | 832,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,590,267 | $915,000 | 0.48% |
| ARMISTICE CAPITAL, LLC | 4,382,000 | $2,520,000 | 0.30% |
| DAFNA Capital Management LLC | 333,000 | $192,000 | 0.12% |
| SABBY MANAGEMENT, LLC | 2,434,103 | $1,400,000 | 0.09% |
| Anson Funds Management LP | 1,024,592 | $589,000 | 0.09% |
| Hartford Financial Management Inc. | 18,000 | $10,000 | 0.01% |
| Summit X, LLC | 11,000 | $7,000 | 0.01% |
| SNS Financial Group, LLC | 18,000 | $10,000 | 0.00% |
| DOWLING & YAHNKE LLC | 22,870 | $13,000 | 0.00% |
| A.R.T. Advisors, LLC | 30,005 | $17,000 | 0.00% |